Abstract:Excessive inflammatory response and apoptosis play key roles in the pathogenic mechanisms of sepsis-induced acute lung injury (ALI); however, the molecular pathways linked to ALI pathogenesis remain unclear. Recently, microRNAs (miRNAs/miRs) have emerged as important regulators of inflammation and apoptosis in sepsis-induced ALI; however, the exact regulatory mechanisms of miRNAs remain poorly understood. In the present study, the gene microarray dataset GSE133733 obtained from the Gene Expression Omnibus database was analyzed and a total of 38 differentially regulated miRNAs were identified, including 17 upregulated miRNAs and 21 downregulated miRNAs, in mice with lipopolysaccharide (LPS)-induced ALI, in comparison to the normal control mice. miR-129 was found to be the most significant miRNA, among the identified miRNAs. The upregulation of miR-129 markedly alleviated LPS-induced lung injury, as indicated by the decrease in lung permeability in and the wet-to-dry lung weight ratio, as well as the improved survival rate of mice with ALI administered miR-129 mimic. Moreover, the upregulation of miR-129 reduced pulmonary inflammation and apoptosis in mice with ALI. Of note, transforming growth factor activated kinase-1 (TAK1), a well-known regulator of the nuclear factor-kappa B (NF-kappa B) pathway, was directly targeted by miR-129 in RAW 264.7 cells. More importantly, miR-129 upregulation impeded the LPS-induced activation of the TAK1/NF-kappa B signaling pathway, as illustrated by the suppression of the nuclear phosphorylated-p65, p-I kappa B-alpha and p-IKK beta expression levels. Collectively, the findings of the present study indicate that miR-129 protects mice against sepsis-induced ALI by suppressing pulmonary inflammation and apoptosis through the regulation of the TAK1/NF-kappa B signaling pathway. This introduces the basis for future research concerning the application of miR-129 and its targets for the treatment of ALI.

MicroRNA-182 supplies negative feedback regulation to ameliorate lipopolysaccharide-induced ALI in mice by targeting TLR4.

Downregulation of TLR4 by Mir-181A Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation

Microrna-106a Provides Negative Feedback Regulation In Lipopolysaccharide-Induced Inflammation By Targeting Tlr4

MicroRNA‑129 Plays a Protective Role in Sepsis‑induced Acute Lung Injury Through the Suppression of Pulmonary Inflammation Via the Modulation of the TAK1/NF‑κB Pathway.

MicroRNA-182-5p Inhibits Inflammation in LPS-treated RAW264.7 Cells by Mediating the TLR4/NF-κB Signaling Pathway.

miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway

Downregulation Of Mir-199a-3p Mediated By The Ctbp2-Hdac1-Foxp3 Transcriptional Complex Contributes To Acute Lung Injury By Targeting Nlrp1

Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.

Upregulation of Mir-146a Contributes to the Suppression of Inflammatory Responses in Lps-Induced Acute Lung Injury

MiR-142a-3p alleviates Escherichia coli derived lipopolysaccharide-induced acute lung injury by targeting TAB2.

Antisense Oligonucleotide Treatment Enhances The Recovery Of Acute Lung Injury Through Il-10-Secreting M2-Like Macrophage-Induced Expansion Of Cd4(+) Regulatory T Cells

Suppressed nuclear factor-kappa B alleviates lipopolysaccharide-induced acute lung injury through downregulation of CXCR4 mediated by microRNA-194.

The suppression of nuclear factor kappa B/microRNA 222 axis alleviates lipopolysaccharide-induced acute lung injury through increasing the alkylglyceronephosphate synthase expression

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

The function and mechanism of microRNA-92a-3p in lipopolysaccharide-induced acute lung injury

miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury.

MicroRNA-9-5p Is Involved in Lipopolysaccharide-Induced Acute Lung Injury Via the Regulation of Macrophage Polarization

MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via Inactivating Cab39/AMPKα Pathway

Mir-497A-5p Attenuates Lipopolysaccharide-Induced Inflammatory Injury by Targeting IRAK2.

MicroRNA‑93 Contributes to the Suppression of Lung Inflammatory Responses in LPS‑induced Acute Lung Injury in Mice Via the TLR4/MyD88/NF‑κB Signaling Pathway.

Macrophage Micro-Rna-155 Promotes Lipopolysaccharide-Induced Acute Lung Injury in Mice and Rats